New horizons in supporting older people's health and wellbeing: is social prescribing a way forward?

New horizons in supporting older people's health and wellbeing: is social prescribing a way forward?
复制标题

DOI:
10.1093/ageing/afaa016
复制
发表时间:
2020-05-01
期刊:
影响因子:
6.7
通讯作者:
Hotham, Sarah
Hotham, Sarah
中科院分区:
医学1区
文献类型:
--
作者:
Hamilton-West, Kate;Milne, Alisoun;Hotham, Sarah

文献摘要

被引文献

相似文献

老年人的健康和护理需求正在发生变化。越来越多的人受到与年龄相关的慢性疾病或残疾、社会孤立和/或心理健康状况不佳的综合影响。社会处方有可能使老年人受益,帮助那些有社交、情感或实际需求的人获得当地社区内的相关服务和资源。然而,研究人员强调了现有证据基础的局限性,而临床医生则对转诊服务的质量、责任和所需的前期投资表示担忧。本文利用 RE-AIM 框架(Glasgow 等,1999)对社会处方证据进行了批判性审查,以确定需要解决的问题,以便为服务的设计和提供以及围绕社会处方不断发展的研究议程提供信息。我们强调研究人员和规划者需要共同努力,开发更强大的证据基础,加深对社会处方(对个人、服务和社区)的影响、与结果变化相关的因素以及实施有效和可持续计划所需的策略的理解。我们还呼吁政策制定者认识到需要对联合倡议进行投资,以解决参与社会处方计划的障碍,为护理人员提供有针对性的支持,并改善老年人获得心理健康服务的机会。我们的结论是,社会处方有潜力支持老年人的健康和福祉,但这种潜力只有通过研究、地方一级实施以及国家政策和投资的战略协调才能实现。
Older people's health and care needs are changing. Increasing numbers live with the combined effects of age-related chronic illness or disability, social isolation and/or poor mental health. Social prescribing has potential to benefit older people by helping those with social, emotional or practical needs to access relevant services and resources within the local community. However, researchers have highlighted limitations with the existing evidence-base, while clinicians express concerns about the quality of onward referral services, liability and upfront investment required. The current article provides a critical review of evidence on social prescribing, drawing on the RE-AIM Framework (Glasgow et al., 1999) to identify questions that will need to be addressed in order to inform both the design and delivery of services and the evolving research agenda around social prescribing. We emphasise the need for researchers and planners to work together to develop a more robust evidence-base, advancing understanding of the impacts of social prescribing (on individuals, services and communities), factors associated with variation in outcomes and strategies needed to implement effective and sustainable programmes. We also call on policymakers to recognise the need for investment in allied initiatives to address barriers to engagement in social prescribing programmes, provide targeted support for carers and improve access to older adult mental health services. We conclude that social prescribing has potential to support older people's health and wellbeing, but this potential will only be realised through strategic alignment of research, local level implementation and national policy and investment.